Phil Bridges Executive Director of Integrated Communications | UNC Health
Phil Bridges Executive Director of Integrated Communications | UNC Health
A range of competitive grants has been awarded to faculty members from the School of Medicine (SOM) for research projects commencing in March 2025. All grants exceed $100,000, with diverse focus areas receiving sponsorship from renowned institutions.
William Kim, with his project "Targeting APOBEC3-induced squamous differentiation in bladder cancer," has secured a grant of $514,582 from the NIH National Cancer Institute, starting on March 1, 2025.
Danielle Roubinov is working on "Developing a scalable digital program to treat youth anxiety," supported by the Fullerton Foundation with a grant of $299,758, beginning the same day.
Jackie Patterson aims to address neonatal care with "Making Every Newborn birth a Learning Event," funded by the Laerdal Foundation with an award of $450,000, also starting on March 1, 2025.
Eva Anton's research, titled "Decoding the Communications of Neuronal Antennae Essential for Neural Circuit Function," has received $100,000 from The Brain and Behavior Research Foundation. This project begins on March 15, 2025.
Charles Perou has received substantial funding of $1,541,280 from the Department of Defense for "The Breast Cancer Cellular Atlas" project, commencing on March 1, 2025.
Martina Kovarova is working on "In-Situ Forming Implant for TB-GMRI Discovery New Chemical Entities (INV 082255)," funded by the Bill and Melinda Gates Foundation with a grant of $532,935, starting on March 5, 2025.
Caroline Thompson's "A Mixed Methods Study of Diagnostic Delay in Ovarian and Uterine Cancer" project is awarded $100,000 by the Ovarian Cancer Research Fund Alliance and will commence on March 1, 2025.
Li Wang's project, "Continued Development of Infant Neuroimaging Analysis Tools," has secured $530,511 from the NIH National Institute of Biomedical Imaging and Bioengineering. The project begins on March 1, 2025.
Finally, Mark Zylka's research on a "Luminescence-based biosensor to non-invasively measure UBE3A activity in the brain" is funded by the NIH National Institute of Neurological Disorders and Stroke with $233,250, starting on March 19, 2025.
These funded initiatives reflect a range of research interests, aiming to advance understanding and treatment across various medical fields.
Alerts Sign-up